AI & Tech··1 sources verified
Isomorphic Labs Raises $5 Billion to Develop AI-Designed Medicines
Summarised by Relevant News AI · Read time: 3 min
Isomorphic Labs, the AI drug discovery company led by Demis Hassabis, has raised $5 billion, according to CNBC. The round comes months after Hassabis stepped down as CEO of Google DeepMind. The company is using AI to develop new medicines.
Why it matters: A $5 billion raise signals heavy investor confidence in AI-driven drug discovery and shows how founders of major AI labs are spinning out well-funded ventures.
All sources